{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-23-000901","form_type":"8-K","ticker":"UTMD","cik":"0000706698","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.969974+00:00","generated_at":"2026-06-16T17:22:13.255752+00:00","sec_items":["2.02","9.01","99.1"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"UTMD Q1 2023: NI +19.2% to $4.2M, EPS $1.16; OUS sales +23%; cash $80.9M","bullets":["Consolidated sales $12.5M, up 1.6% YoY; OUS sales up 23% (28% constant currency), domestic down 10%.","Operating income margin 35.5% (down from 36.7%) due to $348K higher litigation expenses.","Net income $4.2M, EPS $1.16 vs $0.96; NI margin 33.7% vs 28.7%.","Cash and investments $80.9M, up $5.9M from Dec 31, 2022; no debt.","Management reaffirms FY2023 objectives; regular quarterly dividend $0.295/share paid in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-23-000901","json":"https://secwatch.observer/filing/0001096906-23-000901.json","markdown":"https://secwatch.observer/filing/0001096906-23-000901.md","text":"https://secwatch.observer/filing/0001096906-23-000901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/0001096906-23-000901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000901/utmd-20230425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T17:22:13.255752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}